InvestorsHub Logo
Followers 1880
Posts 137776
Boards Moderated 5
Alias Born 01/03/2007

Re: None

Tuesday, 07/05/2016 1:37:03 PM

Tuesday, July 05, 2016 1:37:03 PM

Post# of 364307
NuVasive price target raised to $65 from $58 at Piper Jaffray
Piper Jaffray analyst Matt O'Brien raised his price target for NuVasive to $65 from $58 after the company announced the completion of its acquisition of Biotronic. The analyst also increased his 2016 sales estimate by $27.1M and EPS by 4c, and his 2017 sales projection by $59M and EPS by 10c. Piper Jaffray has an Overweight rating on NuVasive's shares

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.